Johnson & Johnson thinks a longer-acting treatment against schizophrenia will help keep patients on their prescriptions and reduce their chances of a relapse. Now, with a FDA nod under its belt, the company is pushing Invega Hafyera as just the med to fit the bill. The FDA Wednesday approved J&J’s [...]
Cannabidiol linked to reduction in psychotic symptoms in schizophrenia Patients with schizophrenia showed signs of improvement in positive psychotic symptoms and clinician-rated improvement after treatment with cannabidiol, a component of cannabis thought to counteract the effects of tetrahydrocannabinol (THC), an industry-funded phase 2 study reported. According to the authors, the [...]
Allergan plc has announced that the US Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Vraylar (cariprazine) for the maintenance treatment of adults with schizophrenia. Vraylar is also approved in the US in adults for the acute treatment of schizophrenia and acute treatment of [...]
Psychopharmacology Bulletin, V47, N3: Links to In-Depth Articles ORIGINAL PRESENTATIONS Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder. By Brianne Brown, Larry Alphs, Ibrahim Turkoz, Yong Yue Correlation of Caregiver Burden and Baseline Characteristics of Caregivers and Patients [...]
Original Investigation By Jari Tiihonen, MD, Ellenor Mittendorfer-Rutz, Maila Majak; et al Key Points Question Are there any clinically meaningful differences between specific antipsychotic medications or routes of administration regarding the risk of psychiatric rehospitalization or other treatment failure? Findings This database study of a nationwide cohort of patients using within-individual analysis to eliminate [...]
In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]
Researchers have identified six regions of the human genome that are significantly linked to personality traits, and some show significant correlations to certain psychiatric disorders as well. The study, conducted by researchers at the University of California San Diego School of Medicine, is based on a meta-analysis of genome-wide association [...]
Saturday, May 14, 2016. APA Meeting, Atlanta GA. The American Psychiatric Association (APA) convocation, which began today, highlighted initial findings in a number of key and unique mental diseases. Adopting a Dog May Help Veterans with PTSD Adopting a pet dog may prove a useful addition to treatment for veterans [...]
For anyone who has had the great pleasure of reading Siddhartha Mukherjee's 2011 Pulitzer Prize winning "The Emperor of All Maladies: A Biography of Cancer," expect something very special when Dr. Mukherjee's next book, " The Gene: An Intimate History," is published in the Spring. Writing in the March 28, 2016 [...]
From The New York Times, Thursday, January 28. Scientists reported on Wednesday that they had taken a significant step toward understanding the cause of schizophrenia, in a landmark study that provides the first rigorously tested insight into the biology behind any common psychiatric disorder. More than two million Americans have [...]